Advertisement
Opinion

Opinion Opinion articles provide a forum for expression of views, and responses to previous statements, on a range of topical, emerging and controversial issues.

See all article types »

Vaccinomics and Personalized Vaccinology: Is Science Leading Us Toward a New Path of Directed Vaccine Development and Discovery?

  • Gregory A. Poland mail,

    Poland.gregory@mayo.edu

    Affiliation: Mayo Vaccine Research Group, Department of Medicine, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, Minnesota, United States of America

    X
  • Richard B. Kennedy,

    Affiliation: Mayo Vaccine Research Group, Department of Medicine, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, Minnesota, United States of America

    X
  • Inna G. Ovsyannikova

    Affiliation: Mayo Vaccine Research Group, Department of Medicine, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, Minnesota, United States of America

    X
  • Published: December 29, 2011
  • DOI: 10.1371/journal.ppat.1002344

About the Authors

Gregory A. Poland, Richard B. Kennedy, Inna G. Ovsyannikova
Mayo Vaccine Research Group, Department of Medicine, Mayo Clinic College of Medicine, Mayo Foundation, Rochester, Minnesota, United States of America

Corresponding Author

Email: Poland.gregory@mayo.edu

Competing Interests

Dr. Poland and Dr. Ovsyannikova hold patents for the discovery of novel measles and vaccinia peptides potentially useful in developing new diagnostic assays and vaccines. Dr. Poland provides consultative advice to a number of vaccine companies for novel vaccine development (Novartis, PAXVAX, Emergent, Dynavax, Merck, Avianax, Theraclone, Liquidia, EMD Serano), and serves on a DMSB for Merck for clinical trials of novel vaccines in development. Dr. Kennedy has no competing interests.